At a lively drug pricing debate, experts suggest killing off copays - STAT

At a lively drug pricing debate, experts suggest killing off copays - STAT

What to read around the web today

• Transgender health is finally getting researchers' attention. Nature
• Popular heart drugs tainted with carcinogens face a wave of lawsuits. Bloomberg
• U.S. measles cases hit highest mark in 25 years. The Associated Press
• At a lively drug pricing debate, experts suggest killing off copays. STAT Plus
• Long-term use of antibiotics tied to heart risks. The New York Times